Article
ADAM Proteins- Therapeutic Potential in Cancer
1 Dec 2008
Abstract excerpt
The A Disintegrin And Metalloprotease (ADAM) proteins belong to the metzincin-superfamily of Zn-dependent metalloproteinases that shed the extracellular domains of membrane-bound growth factors, cytokines and their receptors. The latter play a central role in cell signaling and contribute a potential target in cancer therapy. Of particular interest are the ErBB/HER family of growth factor receptors associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
